scholarly article | Q13442814 |
P356 | DOI | 10.1097/MD.0000000000004792 |
P8608 | Fatcat ID | release_lbxztiti6redjen3rhdcu5fncy |
P932 | PMC publication ID | 5023908 |
P698 | PubMed publication ID | 27603385 |
P2093 | author name string | Ting-Yu Li | |
Yu-Hsun Wang | |||
James Cheng-Chung Wei | |||
Jeng-Yuan Chiou | |||
Pui-Ying Leong | |||
Kai-Jieh Yeo | |||
Li-Chih Wu | |||
P2860 | cites work | Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis | Q24555478 |
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group | Q28138338 | ||
Selective COX-2 inhibition improves endothelial function in coronary artery disease | Q28194726 | ||
Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction | Q28214120 | ||
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial | Q28217835 | ||
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention | Q29620087 | ||
Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. | Q33178529 | ||
Conventional treatments for ankylosing spondylitis. | Q34967537 | ||
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study | Q36757060 | ||
Cardiovascular events in ankylosing spondylitis: an updated meta-analysis | Q38279570 | ||
Mortality in ankylosing spondylitis: results from a nationwide population-based study | Q41016710 | ||
COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease | Q44182620 | ||
Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly | Q44316505 | ||
Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension | Q44642006 | ||
Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults | Q44851038 | ||
Cyclooxygenase-2 inhibitors and most traditional nonsteroidal anti-inflammatory drugs cause similar moderately increased risks of cardiovascular disease | Q46743815 | ||
Ankylosing spondylitis | Q54165668 | ||
Antirheumatic drug use and the risk of acute myocardial infarction | Q80016233 | ||
P433 | issue | 36 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | sulfasalazine | Q420035 |
ankylosing spondylitis | Q52849 | ||
P304 | page(s) | e4792 | |
P577 | publication date | 2016-09-01 | |
P1433 | published in | Medicine | Q15716652 |
P1476 | title | Celecoxib and sulfasalazine had negative association with coronary artery diseases in patients with ankylosing spondylitis: A nation-wide, population-based case-control study | |
P478 | volume | 95 |
Q54115193 | Celecoxib exerts protective effects in the vascular endothelium via COX-2-independent activation of AMPK-CREB-Nrf2 signalling. |
Q90142748 | Nonsteroidal Anti-inflammatory Drug use is Associated with Incident Hypertension in Ankylosing Spondylitis |
Q30239856 | Should axial spondyloarthritis without radiographic changes be treated with anti-TNF agents? |
Q33848290 | The effect of anti-rheumatic medications for coronary artery diseases risk in patients with rheumatoid arthritis might be changed over time: A nationwide population-based cohort study. |
Search more.